Erektile Dysfunktion – Abklärung und Therapie

Extended Abstract
  • 2 Downloads

Erectile dysfunction: evaluation and treatment

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

P. Maletzki gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Braun M et al (2000) Epidemiology of erectile dysfunction: results of the ‚Cologne Male Survey‘. Int J Impot Res 12(6):305–311CrossRefPubMedGoogle Scholar
  2. 2.
    Capogrosso P et al (2013) One patient out of four with newly diagnosed erectile dysfunction is a young man – worrisome picture from the everyday clinical practice. J Sex Med 10(7):1833–1841CrossRefPubMedGoogle Scholar
  3. 3.
    Sanda MG et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250–1261CrossRefPubMedGoogle Scholar
  4. 4.
    Sikka SC et al (2013) Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med 10(1):120–129CrossRefPubMedGoogle Scholar
  5. 5.
    Sohn M et al (2013) Standard operating procedures for vascular surgery in erectile dysfunction: revascularization and venous procedures. J Sex Med 10(1):172–179CrossRefPubMedGoogle Scholar
  6. 6.
    Goldstein I et al (1998) Oral sildenafil in the treatment of erectile dysfunction. J Urol 167(2 Pt 2):1197–1203 (discussion 1204)Google Scholar
  7. 7.
    Curran M et al (2003) Tadalafil. Drugs 63(20):2203–2212 (discussion 2213–2214)CrossRefPubMedGoogle Scholar
  8. 8.
    Chung E et al (2011) A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother 12(8):1341–1348CrossRefPubMedGoogle Scholar
  9. 9.
    Giovanni C et al (2016) The safety and efficacy of Avanafil, a new 2 generation PDE5i: comprehensive review and meta-analysis. Expert Opinion on Drug Safety 15(2):237–247CrossRefGoogle Scholar
  10. 10.
    Goldstein I et al (2012) A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Avanafil in subjects with erectile dysfunction. J Sex Med 9(4):1122–1133PubMedGoogle Scholar
  11. 11.
    Salonia A et al (2012) Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol 62(2):273–286CrossRefPubMedGoogle Scholar
  12. 12.
    Montorsi F et al (2005) Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2(5):658–667CrossRefPubMedGoogle Scholar
  13. 13.
    Brock G et al (2003) Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 170(4 Pt 1):1278–1283CrossRefPubMedGoogle Scholar
  14. 14.
    Montorsi F et al (2004) Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 172(3):1036–1041CrossRefPubMedGoogle Scholar
  15. 15.
    Porst H et al (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10(1):130–171CrossRefPubMedGoogle Scholar
  16. 16.
    Natali A et al (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5(6):1503–1512CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Urologie, EBU Certified Training CentreKantonsspital WinterthurWinterthurSchweiz

Personalised recommendations